Re: Another reason for Zenith to get busy with a Nasdaq listing

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

narmac

Rank: Vice President [?]

Points: 3973 [?]

Votes: 36 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Another reason for Zenith to get busy with a Nasdaq listing

in response to

Another reason for Zenith to get busy with a Nasdaq listing

masila

posted on Oct 03, 2016 09:10PM

http://www.marketwatch.com/story/biotech-stocks-have-plenty-of-catalysts-around-the-corner-2016-09-30

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply